Avixgen
CEO Message
History
Partnership
Location
Platform Technology
ACP™
a highly efficient cell-penetrating peptide-based
drug delivery system
Angiogenesis inhibitor
Pipeline
Clinical and development status
Medicines
AVI-4015
A drug for dry eye syndrome
AVI-3207
A drug for age-related macular degeneration
AVI-3307
A drug for atopic dermatitis
ACP-
platform
ENG
KOR
Avixgen
CEO Message
History
Partnership
Location
Platform Technology
ACP™
a highly efficient cell-penetrating peptide-based
drug delivery system
Angiogenesis inhibitor
Pipeline
Clinical and development status
Medicines
AVI-4015
A drug for dry eye syndrome
AVI-3207
A drug for age-related macular degeneration
AVI-3307
A drug for atopic dermatitis
ACP-
platform
Avixgen
Avixgen
CEO Message
History
Partnership
Location
Platform Technology
ACP™
a highly efficient cell-penetrating peptide-based
drug delivery system
Angiogenesis inhibitor
Pipeline
Clinical and development status
Medicines
AVI-4015
A drug for dry eye syndrome
AVI-3207
A drug for age-related macular degeneration
AVI-3307
A drug for atopic dermatitis
ACP-
platform
Avixgen
Avixgen
CEO Message
History
Partnership
Location
Platform Technology
ACP™
a highly efficient cell-penetrating peptide-based
drug delivery system
Angiogenesis inhibitor
Pipeline
Clinical and development status
Medicines
AVI-4015
A drug for dry eye syndrome
AVI-3207
A drug for age-related macular degeneration
AVI-3307
A drug for atopic dermatitis
ACP-
platform
Partnership
Avixgen
CEO Message
History
Partnership
Location
Platform Technology
ACP™
a highly efficient cell-penetrating peptide-based
drug delivery system
Angiogenesis inhibitor
Pipeline
Clinical and development status
Medicines
AVI-4015
A drug for dry eye syndrome
AVI-3207
A drug for age-related macular degeneration
AVI-3307
A drug for atopic dermatitis
ACP-
platform
Partnership
Partner institutions for clinical studies
Seoul National University Hospital
Severance Hospital
Ajou University Hospital
Kyungpook National University Hospital
Seoul St. Mary's Hospital
SNUH Bundang
HCMC Tropical Diseases Hospital
National Tropical Diseases Hospital
CRO/CMO
LSK
KNOTUS
MEDITIP
GENIA
ANYGEN
Korea Kolmar
Pan Gen
NOVOTECH
CHEMPEPTIDE
JW shinyak
DongKook Pharmaceutical
HANLIM PHARM
ChemOn
G2Gbio
U&i
l2science
HORUS
Investment partners
LB investment
Hyundai Venture Investment Corporation
HYUNDAI M Partners
HB investment
WONIK investment partners
KOREA INVESTMENT MANAGEMENT
Renaissance asset management
